Targeting type 2 inflammation in dermatology: mechanisms and clinical implications. [PDF]
Khalil N, Farhadi L, Yosipovitch G.
europepmc +1 more source
An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis. [PDF]
Williams EE, Vuppalanchi R.
europepmc +1 more source
Effectiveness and renal safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis patients with chronic kidney disease stages 4-5: a real-world cohort study in China. [PDF]
Hu G, Zhang Q, Yang L, Hu Y, Chen J.
europepmc +1 more source
Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study. [PDF]
Cascio Ingurgio R +6 more
europepmc +1 more source
Dramatic Improvement of Treatment-Refractory Prurigo Nodularis Following Initiation of Semaglutide: A Case Report. [PDF]
Fougerousse AC.
europepmc +1 more source
Atopic dermatitis and attention-deficit/hyperactivity disorder comorbidity in children and adolescents: Epidemiology, mechanisms, and clinical management. [PDF]
Zhao Q +11 more
europepmc +1 more source
Real-World Effectiveness of Secukinumab in Congenital Ichthyoses: A Retrospective Monocentric Case Series. [PDF]
Crespi O +8 more
europepmc +1 more source
Sepsis Secondary to Crusted Scabies Following Iatrogenic Treatment for Hansen's Disease in an Indigenous Amazonian Patient: A Case Report. [PDF]
da Silva ABN +4 more
europepmc +1 more source
Odevixibat for progressive familial intrahepatic cholestasis and Alagille syndrome-associated cholestatic pruritus. [PDF]
europepmc +1 more source
Pruritus associated with systemic sclerosis: a systematic review of treatment-based clinical trials. [PDF]
Mortezaei K +9 more
europepmc +1 more source

